|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
DNAtriX, Inc.
Business Summary
DNAtriX, Inc. is a privately-held, venture capital backed biotechnology company that focuses on the development of an oncoloytic virus platform for the treatment of malignant glioma. The company's product portfolio includes delta24RGD, an oncolytic adenovirus. Founded in 2009, DNAtriX, Inc. is headquartered in Houston, Texas.
Overview & Corporate Organization
Basic Information
| Company Tags: | VC Backed |
| Year Founded: | 2009 |
| Fiscal Year End: | 12/31 |
| City: | Houston |
| State/Province: | Texas |
| Country: | United States |
| Phone: | View |
| Website: | www.dnatrix.com |
Industry Information
PrivCo Industries (Sector > Industry > Sub-Industry)
| Technology > Biotechnology > Other Biotechnology |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Mergers & Acquisitions
| Date | Status | Target | Buyer | Deal Type | Price | |
| Details | Oct. 2012 | Completed | View | View | Acquisition | View |
Missing a deal? Tell us about it! tips@privco.com
VC/Funding Activity
| Date | Investor | Round | Investor Type | |
| Sep. 2008 | View | Other | Venture Capital | |
| Sep. 2008 | View | Other | Venture Capital | |
| Details | Total Round Other View | |||
| Total of Funding Shown Above View | ||||
Missing a deal? Tell us about it! tips@privco.com
Supplemental Resources
|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |




